Quest Diagnostics to Speak at the 2012 Barclays Capital Global Healthcare Conference
MADISON, N.J., March 7, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the 2012 Barclays Capital Global Healthcare Conference in Miami. The presentation is scheduled for Wednesday, March 14, 2012 at 4:15 p.m. Eastern Time.
The presentation will be webcast live during the conference and will be available to registered investors on the following site: http://cc.talkpoint.com/barc002/031312a_lp/?entity=26_S0EGVYM and to the public on www.QuestDiagnostics.com/investor. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until April 13, 2012.
Quest Diagnostics Incorporated is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at: www.QuestDiagnostics.com. Follow us at Facebook.com/QuestDiagnostics and Twitter.com/QuestDX.
Kathleen Valentine (Investors): 973-520-2900
Wendy Bost (Media): 973-520-2800
SOURCE Quest Diagnostics
More by this Source
Patients Nationwide Now Have Direct Access to Lab Test Results through Quest Diagnostics
Apr 07, 2014, 12:46 ET
Quest Diagnostics To Release First Quarter 2014 Financial Results On April 24
Apr 03, 2014, 17:19 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.